Patient Insurance Resources

At Jura Health, we support patients and families as they navigate insurance coverage related to genomic testing. These resources are designed to help you understand and respond to insurance decisions, including coverage requests and appeals.

Available Resources

Request for Coverage Approval: Outpatient Diagnostic Whole Genome Sequencing (WGS)

This template can be used to provide rationale for coverage based on medical and medicaid guidelines

Sample Letter of Appeal

A template you may use if your insurance company has denied coverage for genetic or genomic testing. This resource can help you organize and communicate your appeal.

Commonly Referenced Medical Guidelines

American College of Medical Genetics and Genomics (ACMG)

Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)

American Academy of Pediatrics Guidelines

The American Academy of Pediatrics’ June 23, 2025 clinical report supports a genetics-first approach when evaluating children with intellectual disability or global developmental delay. Based on input from academic clinicians, families and care teams are encouraged to include this document with insurance submissions or appeals to help support the medical need for genomic testing.

Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disorders

A comprehensive evidence review shows that using genome sequencing as a first-line diagnostic test for rare genetic disorders significantly improves diagnostic yield and clinical decision-making compared with traditional stepwise testing, supporting earlier, more effective care.

Download
Download
More Information
More Information

Commonly Referenced Economic Justification

The Cost of Delayed Diagnosis in Rare Disease: A Health Economic Study

A landmark report showing the cost savings of receiving a more timely diagnosis in rare diseases. The economic impact of a delayed diagnosis is up to $517,000 in avoidable costs per patient. Shortening the more than six-year average diagnostic odyssey saves money for individuals, caregivers, and the healthcare system, while improving health outcomes.

More Information
More Information

Patient Support

If you have questions about these resources or would like help understanding next steps, our team is here to support you.

Email: info@jura.health
Phone: (888) 420-0507